---
title: "Oncology estimand working group: conferences and presentations"
author: "A cross-industry international working group"
date: '07 Jun 2021'
output:
  html_document:
    keep_md: true
    toc: yes
    toc_depth: 2
    toc_float:
      collapsed: yes
      smooth_scroll: yes
      number_sections: true
  github_document: 
    toc: true
    toc_depth: 2
  pdf_document:
    toc: yes
  word_document:
    fig_caption: yes
    toc: yes
---



[Back to main site](http://www.oncoestimand.org)




# HTA EFSPI SIG 1-day event {.tabset .tabset-fade .tabset-pills} 


----------------------------------------------
   Start       City    Country       Type     
------------ -------- --------- --------------
 2019-02-15   Berlin   Germany   Invited talk 
----------------------------------------------

## Program

[Link to Program](https://www.efspi.org/documents/events/Events%202019/HTA_Feb_19/EFSPI%20HTA%20Flyer%20Feb%202019%20draft%20updated-converted.pdf)

## Talks




|Speaker (click on title to download slides)                                                     |
|:-----------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [Estimands in Oncology](talks/Estimands in Oncology_EFSPI_HTA_SIG_Berlin.pdf) |



# DAGStat 2019 {.tabset .tabset-fade .tabset-pills} 


---------------------------------------------------
   Start       City    Country         Type        
------------ -------- --------- -------------------
 2019-03-18   Munich   Germany   Contributed talks 
---------------------------------------------------

## Program

[Link to Program](https://www.conftool.org/dagstat2019/index.php?page=browseSessions&form_session=77#paperID316)

## Talks




|Speaker (click on title to download slides)                                                                                                                         |
|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Estimand framework in Oncology drug development -- impact and opportunities](talks/Dagstat2019_1_Rufibach_Estimands_Oncology.pdf)                 |
|Bjoern Bornkamp: [Estimation of Principal Stratum Effects, an Overview and Potential Applications in Oncology](talks/Dagstat2019_2_Bornkamp_PS.pdf)                 |
|Viktoriya Stalbovskaya: [Estimands in the presence of treatment switching](talks/Dagstat2019_3_Stalbovskaya - Estimands in the presence of treatment switching.pdf) |
|Hans-Jochen Weber: [Implementation of the ICH E9 addendum: RATIFY -A case study in hematology](talks/Dagstat2019_4_Weber_estimand_heme.pdf)                         |



# LIDS 2019 {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------------------------
   Start         City      Country              Type             
------------ ------------ --------- -----------------------------
 2019-05-29   Pittsburgh     USA     Contributed talks including 
                                           EMA discussant        
-----------------------------------------------------------------

## Program

[Link to Program](http://lids2019.pitt.edu/)

## Talks




|Speaker (click on title to download slides)                                                                                                                      |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Jonathan Siegel: [Survival Design Strategies in an Estimands Framework](talks/Siegel (2019, talk) Survival Design Strategies in an Estimands Framework.pdf)      |
|Shoubhik Mondal: [Traditional sensitivity analyses in oncology clinical trials what questions are they answering?](talks/Mondal (2019, LIDS talk) Censoring.pdf) |
|Feng Liu: [Developing Estimands in Oncology Trials: Understand Scientific Questions of Interest](talks/Liu (2019, LIDS talk) Estimands in oncology.pdf)          |
|Anja Schiel (EMA discussant): [ICH E9(R1) Addendum Blessing or curse?](talks/Schiel (2019) ICH E9(R1) Addendum – Blessing or curse.pdf)                          |



# PSI annual conference 2019 {.tabset .tabset-fade .tabset-pills} 


---------------------------------------------------
   Start       City    Country         Type        
------------ -------- --------- -------------------
 2019-06-02   London     UK      Contributed talks 
---------------------------------------------------

## Program

[Link to Program](https://www.psiweb.org/psi-conference-2019)

## Talks




|Speaker (click on title to download slides)                                                                                                                            |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Estimand framework in Oncology drug development – impact and opportunities](talks/Rufibach (2019, talk PSI) Estimands_Oncology.pdf)                  |
|Bjoern Bornkamp: [Estimation of Principal Stratum Effects, an Overview and Potential Applications in Oncology](talks/Bornkamp (2019, talk PSI) causal in oncology.pdf) |



# DIA Annual meeting 2019 {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------------
   Start        City      Country         Type       
------------ ----------- --------- ------------------
 2019-06-23   San Diego     USA     Contributed talk 
-----------------------------------------------------

## Program

[Link to Program](https://www.diaglobal.org/en/flagship/dia-2019/about/conference)

## Talks




|Speaker (click on title to download slides)                                                                                                            |
|:------------------------------------------------------------------------------------------------------------------------------------------------------|
|Yi Liu: [Estimand Framework and its Impact on Oncology Drug Development: Findings From An Industry Wide Working Group](talks/Liu (2019, DIA talk).pdf) |



# ISCB 2019 {.tabset .tabset-fade .tabset-pills} 


--------------------------------------------------
   Start       City    Country         Type       
------------ -------- --------- ------------------
 2019-07-14   Leuven   Belgium   Contributed talk 
--------------------------------------------------

## Program

[Link to Program](https://kuleuvencongres.be/iscb40)

## Talks




|Speaker (click on title to download slides)                                                                   |
|:-------------------------------------------------------------------------------------------------------------|
|Rui Tang: [Estimands in the Presence of Treatment Switching](talks/Tang (2019, ISCB) Treatment Switching.pdf) |



# Joint Statistical Meetings 2019 {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------------------
   Start       City    Country             Type            
------------ -------- --------- ---------------------------
 2019-07-27   Denver     USA     Topic contributed session 
-----------------------------------------------------------

## Program

[Link to Program](http://ww2.amstat.org/meetings/jsm/2019/)

## Talks




|Speaker (click on title to download slides)                                                                                                                                       |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [Estimand framework in Oncology drug development impact and opportunities](talks/JSM19_1_Degtyarev Estimands in oncology.pdf)                                   |
|Jonathan Siegel: [Importance of censoring mechanisms in selecting appropriate estimands](talks/JSM19_2 Importance of censoring mechanisms in selecting appropriate estimands.pdf) |
|Steven Sun: [Sensitivity Analysis vs Supportive Analysis under Estimand Framework: A Case Study in Hematological Malignancies](talks/JSM19_3 sensitivity analyses.pdf)            |
|Michelle Casey: [Estimand Framework - Are we asking the right questions? A case study in the solid tumor setting](talks/JSM19_4 right questions.pdf)                              |



# EFSPI Regulatory Statistics Workshop 2019 {.tabset .tabset-fade .tabset-pills} 


-------------------------------------------------
   Start      City      Country         Type     
------------ ------- ------------- --------------
 2019-09-23   Basel   Switzerland   Invited talk 
-------------------------------------------------

## Program

[Link to Program](https://www.efspi.org/EFSPI/Events/Regulatory_Meetings/4th_efspi_workshop_on_regulatory_statistics.aspx)

## Talks




|Speaker (click on title to download slides)                                                                                                                                                  |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [Estimand framework: opportunity to rethink some old (and new) problems in Oncology trials?](talks/Degtyarev (2019, EFSPI) Estimand framework, opportunity to rethink.pdf) |



# ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2019 {.tabset .tabset-fade .tabset-pills} 


------------------------------------------------------------------
   Start         City      Country               Type             
------------ ------------ --------- ------------------------------
 2019-09-23   Washington     USA     Contributed talks (including 
                                           FDA discussant)        
------------------------------------------------------------------

## Program

[Link to Program](https://ww2.amstat.org/meetings/biop/2019/)

## Talks




|Speaker (click on title to download slides)                                                                                                                                                                                           |
|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Feng Liu: [Causal Estimand and Principal Stratum, an Overview and Potential Applications in Oncology](talks/Liu (2019, ASA biopharm) Causal Estimand and Principal Stratum.pdf)                                                       |
|Jiangxiu Zhou: [Estimands for PFS2](talks/Zhou (2019, ASA) Estimands PFS2.pdf)                                                                                                                                                        |
|Alexei C. Ionan (FDA discussant): [Estimand Framework in Oncology Drug Development: Challenges and Opportunities](talks/Ionan (2019, ASA biopharm) Estimand Framework in Oncology Drug Development, Challenges and Opportunities.pdf) |



# ESMO 2019 {.tabset .tabset-fade .tabset-pills} 


-------------------------------------------
   Start        City      Country    Type  
------------ ----------- --------- --------
 2019-09-27   Barcelona    Spain    Poster 
-------------------------------------------

## Program

[Link to Program](https://www.esmo.org/Conferences/ESMO-2019-Congress)

## Talks




|Speaker (click on title to download slides)                                                                                                                                                  |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Daniel George: [Impact of estimand selection on adjuvant treatment outcomes in renal cell carcinoma (RCC)](talks/George (2019, ESMO) renal.pdf)                                              |
|Bryant Furlow: [Commentary on poster](https://www.cancertherapyadvisor.com/home/cancer-topics/renal-cell-carcinoma/getting-more-specific-about-adjuvant-therapy-effects-in-kidney-cancer/2/) |



# ISOQoL 2019 {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------------
   Start        City      Country         Type       
------------ ----------- --------- ------------------
 2019-10-20   San Diego     USA     Contributed talk 
-----------------------------------------------------

## Program

[Link to Program](https://www.isoqol.org/wp-content/uploads/2019/09/ac19-FP-web.pdf)

## Talks




|Speaker (click on title to download slides)                                                                                                   |
|:---------------------------------------------------------------------------------------------------------------------------------------------|
|Rachael Lawrance: [Using PROs in clinical trials: what should I know about?](talks/Lawrance (2019, ISOQoL) Using PROs in clinical trials.pdf) |



# Webinar of the Basel Biometrics Section: Impact of COVID-19 on clinical trials {.tabset .tabset-fade .tabset-pills} 


---------------------------------------------------
   Start       City       Country         Type     
------------ --------- ------------- --------------
 2020-05-06   Webinar   Switzerland   Invited talk 
---------------------------------------------------

## Program

[Link to Program](http://bbs.ceb-institute.org/?p=1476)

## Talks




|Speaker (click on title to download slides)                                                                                                                                                                |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [Short overview on COVID-19 from the Cross-Industry Oncology Estimands Working Group](http://bbs.ceb-institute.org/wp-content/uploads/2020/05/BBS-Webinar-covid19-onco-estimand-WG.pptx) |



# Estimands in Oncology Virtual Panel Discussion (organized by Cytel) {.tabset .tabset-fade .tabset-pills} 


------------------------------------------------------------
   Start       City     Country             Type            
------------ --------- --------- ---------------------------
 2020-05-21   Webinar     USA     Invited talk and panelist 
------------------------------------------------------------

## Program

[Link to Program](https://www.cytel.com/webinar-replay-estimands-in-oncology?utm_campaign=2020%20Consulting%20EMAIL&utm_medium=email&_hsenc=p2ANqtz--WN5H59zPBQopCVp-byMemvtjmBivRttoe7iWN_pcetDWhMyrW_-UdxjqoY6Ggd6S8rgrUhTglXMMhThNVuFTnMbqx0g&_hsmi=88689056&utm_source=hs_email&utm_content=88689056&hsCtaTracking=3db4881a-8653-4be6-8b0f-2be87253acee%7C42deeaa9-95eb-4bb9-b67e-ed5709cbc6db)

## Talks




|Speaker (click on title to download slides)                                                           |
|:-----------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Estimands in oncology](https://www.cytel.com/hubfs/Rufibach_estimands_oncology.pdf) |
|Michelle Casey: [NA](NA)                                                                              |



# PSI Conference Webinar: Impact of COVID-19 to estimands {.tabset .tabset-fade .tabset-pills} 


------------------------------------------------------------
   Start       City     Country             Type            
------------ --------- --------- ---------------------------
 2020-06-11   Webinar     UK      Invited talk and panelist 
------------------------------------------------------------

## Program

[Link to Program](https://www.psiweb.org/events/event-item/2020/06/11/default-calendar/psi-conference-webinar-impact-of-covid-19-to-estimands)

## Talks




|Speaker (click on title to download slides)                                                                                                                           |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Application of the estimand framework to assess the impact of COVID-19 on clinical trials](talks/Rufibach (2020, PSI) estimands_oncology_covid.pdf) |



# Webinar of the Basel Biometrics Section: Estimands addendum is final: Anything new for oncology? {.tabset .tabset-fade .tabset-pills} 


---------------------------------------------------
   Start       City       Country         Type     
------------ --------- ------------- --------------
 2020-06-29   Webinar   Switzerland   Invited talk 
---------------------------------------------------

## Program

[Link to Program](http://bbs.ceb-institute.org/?p=1453)

## Talks




|Speaker (click on title to download slides)                                                                                                                                |
|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Introduction](talks/0_Rufibach.pdf)                                                                                                                      |
|Anja Schiel: [Experiences with the estimand - the regulatory view](talks/1_Schiel.pdf)                                                                                     |
|Renaud Capdeville: [Challenges and open questions in hematology: Estimand aspects in the RATIFY trial](talks/2_Capdeville_Weber_RATIFY.pdf)                                |
|Tina Nielsen: [Challenges and open questions in hematology: Estimand aspects in the Gallium trial](talks/3_Nielsen_GALLIUM.pdf)                                            |
|Hannes Buchner & Ingolf Griebsch: [Estimands in clinical trials with treatment switching](talks/4_Griebsch_Buchner.pdf)                                                    |
|Stefan Englert: [Commentary on previous talks taking COVID 19 into account](talks/5_Englert.pdf)                                                                           |
|All: [Recording of the entire event](https://streamingmedia.roche.com/media/Joint+EFSPI+++BBS+SeminarA+Estimands+addendum+is+finalA+Anything+new+for+oncologyF/1_3wavzkyv) |
|All: [Q&A document answering questions raised in chat during webinar](talks/6_Q_and_A.pdf)                                                                                 |



# Joint Statistical Meetings 2020 {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------------------------
   Start          City       Country             Type            
------------ -------------- --------- ---------------------------
 2020-08-01   Philadelphia     USA     Topic contributed session 
-----------------------------------------------------------------

## Program

[Link to Program](https://ww2.amstat.org/meetings/jsm/2020/)

## Talks




|Speaker (click on title to download slides)                                                                                         |
|:-----------------------------------------------------------------------------------------------------------------------------------|
|Jonathan Siegel: [Estimand Framework and Its Impact on Drug Development in Oncology](talks/JSM20_Siegel et a, panel discussion.pdf) |
|Anja Schiel: [NA](NA)                                                                                                               |
|Kunthel By: [NA](NA)                                                                                                                |
|Catherine Njue: [NA](NA)                                                                                                            |
|Richard J. Cook: [NA](NA)                                                                                                           |



# Webinar of the Basel Biometrics Section: RCTs meeting causal inference: principal stratum strategy and beyond {.tabset .tabset-fade .tabset-pills} 


---------------------------------------------------
   Start       City       Country         Type     
------------ --------- ------------- --------------
 2020-09-07   Webinar   Switzerland   Invited talk 
---------------------------------------------------

## Program

[Link to Program](http://bbs.ceb-institute.org/?p=1587)

## Talks




|Speaker (click on title to download slides)                                                                                                                |
|:----------------------------------------------------------------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Introduction](http://bbs.ceb-institute.org/wp-content/uploads/2020/09/01-Rufibach.pdf)                                                   |
|Bjoern Bornkamp: [Principal Stratum Strategy: Potential Role in Drug Development](http://bbs.ceb-institute.org/wp-content/uploads/2020/09/05-Bornkamp.pdf) |



# ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2020 {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------
   Start       City     Country       Type     
------------ --------- --------- --------------
 2020-09-22   Virtual     USA     Invited talk 
-----------------------------------------------

## Program

[Link to Program](https://ww2.amstat.org/meetings/biop/2020/)

## Talks




|Speaker (click on title to download slides)                                                                            |
|:----------------------------------------------------------------------------------------------------------------------|
|Jonathan Siegel: [Industry Perspective on Subsequent Therapy: An Estimands Approach](talks/ASA20_Siegel_switching.pdf) |



# Joint PSI, EFSPI & ASA BIOP Webinar: Estimands {.tabset .tabset-fade .tabset-pills} 


------------------------------------------------
   Start       City     Country        Type     
------------ --------- ---------- --------------
 2020-11-05   Virtual   UK / USA   Invited talk 
------------------------------------------------

## Program

[Link to Program](https://www.psiweb.org/vod/item/joint-psi-efspi-asa-biop-webinar-estimands)

## Talks




|Speaker (click on title to download slides)                                                                                     |
|:-------------------------------------------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [Estimand framework: What are the opportunities in oncology?](talks/Degtyarev_2020_asa_psi_efspi_webinar.pdf) |



# The effective statistician podcast: A deep dive into principal stratification and causal inference {.tabset .tabset-fade .tabset-pills} 


-------------------------------------------------
   Start       City       Country        Type    
------------ --------- ------------- ------------
 2020-11-17   Podcast   Switzerland   Discussion 
-------------------------------------------------

## Program

[Link to Program](https://theeffectivestatistician.com/a-deep-dive-into-principal-stratification-and-causal-inference/)

## Talks




|Speaker (click on title to download slides)                                                                                              |
|:----------------------------------------------------------------------------------------------------------------------------------------|
|Kaspar Rufibach: [Link to podcast](https://theeffectivestatistician.com/a-deep-dive-into-principal-stratification-and-causal-inference/) |
|Bjoern Bornkamp: [Link to podcast](https://theeffectivestatistician.com/a-deep-dive-into-principal-stratification-and-causal-inference/) |



# Working group "Pharmaceutical Industry" of the German Region of the IBS (APF) {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------
   Start       City     Country       Type     
------------ --------- --------- --------------
 2020-11-27   Virtual   Germany   Invited talk 
-----------------------------------------------

## Program

[Link to Program](http://www.biometrische-gesellschaft.de/fileadmin/AG_Daten/PharamzeutischeForschung/PDFs/Agenda_APF_74_virtuell_Nov_2020.pdf)

## Talks




|Speaker (click on title to download slides)                                                                                              |
|:----------------------------------------------------------------------------------------------------------------------------------------|
|Hannes Buchner: [Estimands update: Summary of world-wide authority interaction](talks/Buchner_Rufibach_HAinteractions_PS_switching.pdf)  |
|Kaspar Rufibach: [Estimands update: Summary of world-wide authority interaction](talks/Buchner_Rufibach_HAinteractions_PS_switching.pdf) |



# The 76th Annual Deming Conference on Applied Statistics {.tabset .tabset-fade .tabset-pills} 


----------------------------------------------
   Start       City     Country      Type     
------------ --------- --------- -------------
 2020-12-09   Virtual     USA     Shortcourse 
----------------------------------------------

## Program

[Link to Program](https://demingconference.org/topic/session-j/)

## Talks




|Speaker (click on title to download slides)                                                                                                               |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [Answering Old Questions with New Tools: Application of the ICH E9 Addendum in Oncology](talks/Deming2020_ED_KR_estimands_oncology.pdf) |
|Kaspar Rufibach: [Answering Old Questions with New Tools: Application of the ICH E9 Addendum in Oncology](talks/Deming2020_ED_KR_estimands_oncology.pdf)  |



# ASA - FDA - LUNGevity symposium: Statistical considerations in Oncology clinical trials in the COVID-19 era {.tabset .tabset-fade .tabset-pills} 


--------------------------------------------
   Start       City     Country     Type    
------------ --------- --------- -----------
 2021-02-11   Virtual     USA     Symposium 
--------------------------------------------

## Program

[Link to Program](talks/lungevity_agenda.pdf)

## Talks




|Speaker (click on title to download slides)                                                                         |
|:-------------------------------------------------------------------------------------------------------------------|
|Evgeny Degtyarev: [How can the estimand framework support decentralized trials?](talks/20210211_DCTs_estimands.pdf) |
|Kaspar Rufibach: [How can the estimand framework support decentralized trials?](talks/20210211_DCTs_estimands.pdf)  |



# Duke Industry Statistics Symposium {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------
   Start       City     Country       Type     
------------ --------- --------- --------------
 2021-04-21   Virtual     USA     Invited talk 
-----------------------------------------------

## Program

[Link to Program](https://sites.duke.edu/diss/)

## Talks




|Speaker (click on title to download slides)                                       |
|:---------------------------------------------------------------------------------|
|Natalia Kan-Dobrosky: [Estimands in clinical trials with treatment switching](NA) |



# PSI EIWG Webinar: Estimands in Oncology - How and Why {.tabset .tabset-fade .tabset-pills} 


-----------------------------------------------
   Start       City     Country       Type     
------------ --------- --------- --------------
 2021-06-01   Virtual     UK      Invited talk 
-----------------------------------------------

## Program

[Link to Program](https://www.psiweb.org/events/event-item/2021/06/01/default-calendar/psi-eiwg-webinar-estimands-in-oncology---how-and-why)

## Talks




|Speaker (click on title to download slides)                                                                                       |
|:---------------------------------------------------------------------------------------------------------------------------------|
|Stefan Englert: [Bringing estimands to lifelifethrough real case studies through real case studies](talks/20210601_clin_eng.pdf)  |
|Paul Bycott: [Bringing estimands to lifelifethrough real case studies through real case studies](talks/20210601_clin_eng.pdf)     |
|Feng Liu: [Bringing estimands to lifelifethrough real case studies through real case studies](talks/20210601_clin_eng.pdf)        |
|Jonathan Siegel: [Bringing estimands to lifelifethrough real case studies through real case studies](talks/20210601_clin_eng.pdf) |
|Sammi Tang: [Bringing estimands to lifelifethrough real case studies through real case studies](talks/20210601_clin_eng.pdf)      |
|Jiawei Wei: [Bringing estimands to lifelifethrough real case studies through real case studies](talks/20210601_clin_eng.pdf)      |
|All: [Recording of the entire event](NA)                                                                                          |



